Search clinical trials for: Oxaliplatin

Total 1784 results

The First People's Hospital of Changzhou

Completed

TOF Versus SOX in Metastatic Gastric Cancer

Gastric Cancer
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital

Unknown

Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial

Hepatocellular Carcinoma

China
National Health Research Institutes, Taiwan
Mackay Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Terminated

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

Gastric Adenocarcinoma

Taiwan
UNC Lineberger Comprehensive Cancer Center

Withdrawn

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Rectal Adenocarcinoma

United States
Fujian Cancer Hospital

Recruiting

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy Gastrict Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (EXPLORING)

Digestive System Diseases | Gastrointestinal Diseases | Carcinoma | Gastrointestinal Neoplasms | Stomach Cancer | Gastric Cancer | Gastroesophageal-junction Cancer

China
RenJi Hospital

Not yet recruiting

Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric Cancer
Peking Union Medical College Hospital
Geneplus-Beijing Co. Ltd.

Unknown

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Rectal Cancer, Adenocarcinoma | Neoadjuvant Chemoradiation
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Intestine Cancer | Anal Cancer | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer | Gastrointestinal Carcinoid Tumor

United States
Yonsei University

Unknown

Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer

Gastric Cancer

Korea, Republic of
Sanofi

Completed

TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

Colorectal Cancer

United States
Peking University People's Hospital
Peking University; Sanofi

Unknown

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

Colorectal Cancer | Resectable Liver Metastasis

China
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb; Bayer

Active, not recruiting

A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

Esophagogastric Cancer | HER2-Negative

United States
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Metastatic Breast Cancer | Liver Metastases

Denmark
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Metastatic Breast Cancer | Liver Metastases

Denmark
Yu jiren

Recruiting

Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)

Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric Junction | Proficient Mismatch Repair

China
Japan Clinical Cancer Research Organization
Taiho Pharmaceutical Co., Ltd.

Unknown

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

Rectal Carcinoma

Japan
Sanofi

Completed

Oxaliplatin in Gastric Cancer

Stomach Neoplasms
Salah Azaïz Cancer Institute

Active, not recruiting

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Rectal Cancer | Locally Advanced

Tunisia
Zhejiang Cancer Hospital

Not yet recruiting

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Xijing Hospital

Recruiting

Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma

Locally Advanced Gastric Adenocarcinoma

China
Harbin Medical University

Unknown

Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

Stage IV Gastric Cancer With Metastasis

China
Fudan University

Unknown

Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma (NEWEAR)

Gastric Cancer

China
Sanofi

Withdrawn

Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients (SECOX)

Hepatic Neoplasm Malignant
Samsung Medical Center

Completed

Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

Unresectable, Metastatic Biliary Tract Carcinoma

Korea, Republic of
Grupo Espanol Multidisciplinario del Cancer Digestivo

Unknown

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. (BECOX)

Metastatic Colorectal Cancer

Spain
Vejle Hospital

Completed

Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

Cholangiocarcinoma

Denmark
Samsung Medical Center

Unknown

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer

Korea, Republic of
University of California, Irvine
Sanofi

Terminated

Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer

Head and Neck Cancer

United States
Sanofi

Completed

GEMOX: Oxaliplatin in Pancreatic Cancer

Pancreatic Neoplasms

Korea, Republic of
Rabin Medical Center

Unknown

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Liver Metastasis Colon Cancer

Israel
Asan Medical Center

Completed

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Stomach Cancer

Korea, Republic of
Duke University
Merck Sharp & Dohme LLC

Completed

KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer

Gastric Cancer | Esophagus Cancer

United States
Asan Medical Center

Completed

Study of XELOX With Cetuximab in Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Indiana University
Genentech, Inc.

Completed

Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

Neoplasms, Germ Cell and Embryonal

United States
Sanofi

Completed

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

Neoplasms, Germ Cell and Embryonal

France
Sun Yat-sen University

Active, not recruiting

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Advanced Rectal Cancer

China
Peking University

Completed

A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Gastric Cancer

China
National University Hospital, Singapore
Yonsei University; National Cancer Centre, Singapore

Unknown

A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients (3G)

Recurrent Gastric Cancer

Singapore
Zhu Xu

Unknown

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

Colon Cancer Liver Metastasis

China
Spanish Cooperative Group for the Treatment of...
Sanofi; Hoffmann-La Roche

Completed

Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status

Gastric Cancer

Spain
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
The University of Hong Kong

Unknown

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (SECOX)

Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

China
Shanghai Zhongshan Hospital

Not yet recruiting

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Gastric Cancer

China
Michael Bau Mortensen

Recruiting

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Colo-rectal Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Peritoneum Cancer

Denmark
Baylor College of Medicine

Completed

Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease (Corti)

Cardiac Output, Low

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

Stomach Neoplasms

China
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Cholangiocarcinoma

Denmark
Centre Hospitalier Universitaire de Besancon
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer (EROS)

Metastatic Colorectal Cancer

France

3

Subscribe